Emcure Pharma IPO subscription status: Issue subscribed 75% so far on Day 1

Quick Summary:

Emcure Pharma, however, has struggled to boost its profit due to planned expansion using borrowed funds.

The portion reserved for Emcure Pharmaceuticals employees has been subscribed 1.66 times so far, while the portion reserved for NIIs has been booked 1.26x.

The grey market premium (GNP0 of Emcure Pharmaceuticals stood at Rs 295 as on July 3, 2024.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaCanada

Topics: Emcure pharma ipo analysis Emcure pharma gmp Market Emcure pharma subscription status Emcure pharma Business standard Emcure pharma news Namita thapar Emcure pharma ipo status Emcure pharma ipo Emcure pharma share price Emcure pharma subscription

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-03 @ 14:29:06 (2 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 612 words

Reading Time: 4 minutes read

Sentences: 30 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21469915

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 303 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions